FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210532624> ?p ?o ?g. }

• W4210532624 endingPage "550" @default.
• W4210532624 startingPage "544" @default.
• W4210532624 abstract "PARP inhibitors are largely recognized as active drugs in BRCA-mutated breast and ovarian malignancies. In pancreatic ductal adenocarcinoma, the PARP inhibitor olaparib has recently been approved as maintenance treatment in patients with germline BRCA mutations reaching disease control after a platinum-based first line chemotherapy, proving significant benefit on progression free survival. On the other hand, little evidence is available regarding olaparib as single agent after progression with standard treatment in BRCA-mutated pancreatic ductal adenocarcinoma. A 61-year-old female patient harboring germline BRCA2 mutation was treated at our institution for a pancreatic ductal adenocarcinoma with lung and liver metastases. The patient received three previous lines of treatment with standard therapies, as follows: after the third line treatment failure, we started a further line of treatment with olaparib in off-label prescription. After the first two cycles, a CT scan documented partial response, with complete regression of lung metastases. The response was maintained after four cycles, with further response and clinical benefit. The radiologic and clinical response was maintained for 6 months. This case highlights the potential of olaparib as single agent after progression with standard treatment in BRCA-mutated pancreatic cancer." @default.
• W4210532624 created "2022-02-08" @default.
• W4210532624 creator A5012312536 @default.
• W4210532624 creator A5028325185 @default.
• W4210532624 creator A5034356923 @default.
• W4210532624 creator A5036411818 @default.
• W4210532624 creator A5043480941 @default.
• W4210532624 creator A5051613962 @default.
• W4210532624 creator A5067830810 @default.
• W4210532624 date "2022-01-27" @default.
• W4210532624 modified "2023-10-14" @default.
• W4210532624 title "An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer" @default.
• W4210532624 cites W1523531555 @default.
• W4210532624 cites W1898580708 @default.
• W4210532624 cites W1973268287 @default.
• W4210532624 cites W1987313243 @default.
• W4210532624 cites W2009007206 @default.
• W4210532624 cites W2015943054 @default.
• W4210532624 cites W2019607817 @default.
• W4210532624 cites W2106157865 @default.
• W4210532624 cites W2108565008 @default.
• W4210532624 cites W2111437716 @default.
• W4210532624 cites W2117964602 @default.
• W4210532624 cites W2128746885 @default.
• W4210532624 cites W2135525536 @default.
• W4210532624 cites W2138155367 @default.
• W4210532624 cites W2142795777 @default.
• W4210532624 cites W2161479848 @default.
• W4210532624 cites W2235523093 @default.
• W4210532624 cites W2519148856 @default.
• W4210532624 cites W2596919450 @default.
• W4210532624 cites W2804931473 @default.
• W4210532624 cites W2908639608 @default.
• W4210532624 cites W2909786746 @default.
• W4210532624 cites W2917919815 @default.
• W4210532624 cites W2947826965 @default.
• W4210532624 cites W2984359187 @default.
• W4210532624 cites W3001713806 @default.
• W4210532624 cites W3004590183 @default.
• W4210532624 cites W3121978488 @default.
• W4210532624 cites W3159639089 @default.
• W4210532624 cites W4211006558 @default.
• W4210532624 doi "https://doi.org/10.3390/curroncol29020049" @default.
• W4210532624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35200549" @default.
• W4210532624 hasPublicationYear "2022" @default.
• W4210532624 type Work @default.
• W4210532624 citedByCount "3" @default.
• W4210532624 countsByYear W42105326242022 @default.
• W4210532624 countsByYear W42105326242023 @default.
• W4210532624 crossrefType "journal-article" @default.
• W4210532624 hasAuthorship W4210532624A5012312536 @default.
• W4210532624 hasAuthorship W4210532624A5028325185 @default.
• W4210532624 hasAuthorship W4210532624A5034356923 @default.
• W4210532624 hasAuthorship W4210532624A5036411818 @default.
• W4210532624 hasAuthorship W4210532624A5043480941 @default.
• W4210532624 hasAuthorship W4210532624A5051613962 @default.
• W4210532624 hasAuthorship W4210532624A5067830810 @default.
• W4210532624 hasBestOaLocation W42105326241 @default.
• W4210532624 hasConcept C104317684 @default.
• W4210532624 hasConcept C121608353 @default.
• W4210532624 hasConcept C126322002 @default.
• W4210532624 hasConcept C143998085 @default.
• W4210532624 hasConcept C182979987 @default.
• W4210532624 hasConcept C185592680 @default.
• W4210532624 hasConcept C2775930923 @default.
• W4210532624 hasConcept C2779138821 @default.
• W4210532624 hasConcept C2779962180 @default.
• W4210532624 hasConcept C2780194787 @default.
• W4210532624 hasConcept C2780210213 @default.
• W4210532624 hasConcept C2780427987 @default.
• W4210532624 hasConcept C2781182431 @default.
• W4210532624 hasConcept C502942594 @default.
• W4210532624 hasConcept C530470458 @default.
• W4210532624 hasConcept C55493867 @default.
• W4210532624 hasConcept C71924100 @default.
• W4210532624 hasConcept C82381507 @default.
• W4210532624 hasConceptScore W4210532624C104317684 @default.
• W4210532624 hasConceptScore W4210532624C121608353 @default.
• W4210532624 hasConceptScore W4210532624C126322002 @default.
• W4210532624 hasConceptScore W4210532624C143998085 @default.
• W4210532624 hasConceptScore W4210532624C182979987 @default.
• W4210532624 hasConceptScore W4210532624C185592680 @default.
• W4210532624 hasConceptScore W4210532624C2775930923 @default.
• W4210532624 hasConceptScore W4210532624C2779138821 @default.
• W4210532624 hasConceptScore W4210532624C2779962180 @default.
• W4210532624 hasConceptScore W4210532624C2780194787 @default.
• W4210532624 hasConceptScore W4210532624C2780210213 @default.
• W4210532624 hasConceptScore W4210532624C2780427987 @default.
• W4210532624 hasConceptScore W4210532624C2781182431 @default.
• W4210532624 hasConceptScore W4210532624C502942594 @default.
• W4210532624 hasConceptScore W4210532624C530470458 @default.
• W4210532624 hasConceptScore W4210532624C55493867 @default.
• W4210532624 hasConceptScore W4210532624C71924100 @default.
• W4210532624 hasConceptScore W4210532624C82381507 @default.
• W4210532624 hasIssue "2" @default.
• W4210532624 hasLocation W42105326241 @default.
• W4210532624 hasLocation W42105326242 @default.
• W4210532624 hasLocation W42105326243 @default.

• next